Our September 2019 release includes annotations of effects of 222 drugs, mostly chemical drugs in widespread use to treat thrombosis and other cardiovascular diseases. Work is underway to extend annotations to drugs involved in other disease processes, and to other stages of the complete drug life cycle, linking the molecular function of its active form to reactions for its uptake, its activation if it enters the body in prodrug from, and its inactivation and elimination.
